Page 1 of Clinical Trials for Drug triptorelin, 60 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
Last Updated: August 7, 2010
Condition(s): Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Hormonal Changes
2
Active, not recruiting
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Last Updated: July 30, 2010
Condition(s): Ovarian Function Restoration After Chemotherapy for Lymphoma
3
Completed
Efficacy and Safety of a Triptorelin 6-Month Formulation in Patients With Advanced Prostate Cancer
Last Updated: September 11, 2008
Condition(s): Locally Advanced or Metastatic Prostate Cancer
4
Active, not recruiting
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
5
Recruiting
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
6
Active, not recruiting
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Last Updated: November 29, 2011
Condition(s): Prostate Cancer
7
Terminated
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
Last Updated: October 7, 2011
Condition(s): Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
8
Not yet recruiting
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Last Updated: May 8, 2012
Condition(s): Prostate Cancer
9
Active, not recruiting
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Last Updated: February 23, 2012
Condition(s): Prostate Cancer
10
Recruiting
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Last Updated: September 12, 2006
Condition(s): Prostate Cancer
11
Recruiting
Triptorelin for Ovary Protection in Childhood Onset Lupus
Last Updated: August 25, 2011
Condition(s): Systemic Lupus Erythematosus
12
Active, not recruiting
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Last Updated: February 18, 2011
Condition(s): Osteoporosis; Prostate Cancer
13
Completed
Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer
Last Updated: February 6, 2009
Condition(s): Breast Cancer
14
Active, not recruiting
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Last Updated: February 8, 2012
Condition(s): Breast Cancer
15
Recruiting
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
Last Updated: October 26, 2011
Condition(s): Breast Cancer
16
Recruiting
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Last Updated: May 24, 2012
Condition(s): Prostate Cancer
17
Completed
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Last Updated: July 23, 2011
Condition(s): Breast Cancer
18
Active, not recruiting
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Last Updated: January 14, 2011
Condition(s): Central Precocious Puberty; Sexual Precocity
19
Completed
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
Last Updated: April 17, 2007
Condition(s): Infertility
20
Recruiting
Endometrial Receptivity After GnRH Agonist Triggering
Last Updated: December 28, 2011
Condition(s): Ovarian Hyperstimulation Syndrome

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+triptorelin

Page 1 of Clinical Trials for Drug triptorelin, 60 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About